A simple, rapid and sensitive liquid chromatography tandem mass spectrometry method is presented for the simultaneous determination of oleanolic acid, p-coumaric acid, ferulic acid, kaemperol and quercetin in rat plasma. Glycyrrhetinic acid was used as an internal standard, and sample pretreatment consisted of a liquid-liquid extraction. Chromatographic separation was achieved on a Gemini 110A C18 column (50 3 2.0 mm i.d., 5 mm) by gradient elution with a mobile phase consisting of methanol, acetonitrile and 0.01% formic acid in water. Tandem mass spectrometric detection was conducted using multiple reaction monitoring under negative ionization mode. Calibration curves offered linear ranges of two orders of magnitude with r > 0.99. The method was validated in terms of matrix effect, intra-day and inter-day precision, accuracy, linearity, specificity and stability. The relative standard deviation of intra-day and inter-day variations ranged from 2.66 to 14.74% and 1.9 to 14.55%. No substantial endogenous interference from blank plasma was observed. The method has been successfully applied to a pharmacokinetic study of Oldenlandia diffusa extract after oral administration in rats.
Introduction
Oldenlandia diffusa is one of the most extensively used Chinese herbal remedies in modern Chinese practice and officially listed as an ingredient of Chinese patent medicine. The plant is a member of the Rubiaceae family and known as Hedyotis diffusa (botanical name), Herba hedyotis diffusae ( pharmaceutical name) and Bai Hua She She Cao (common name). It is primarily distributed in Southern China and has been used medicinally for many centuries in China (1) . Oldenlandia diffusa has been used for the treatment of hepatitis, tonsillitis, sore throat, appendicitis, urethral infection and malignant tumors of the liver, lung and stomach (2) . Many pharmacological studies of Olenlandia diffusa have demonstrated that it has antitumor, immunomodulatory (3, 4) , anti-mutagenic (5, 6), anti-inflammatory, hepatoprotective (7), anti-oxidative (8, 9) and neuroprotective (10) activities.
Oldenlandia diffusa includes many components. Oleanolic acid (OA), p-coumaric acid ( p-CA), ferulic acid (FA), kaemperol and quercetin are five components existing in Oldenlandia diffusa (10 -13) . OA, present in Oldenlandia diffusa at high abundance, is one of the pentacyclic triterpenoids that exist widely in plants (11) . Studies indicate that the biological activities of OA are multiple, including hepatoprotective, anti-tumor, chemo-preventive, anti-angiogenic, and anti-inflammatory, antioxidant and pro-apoptotic effects (14 -16) . FA is a known antioxidant with various pharmacological properties (17) , and is generally effective as an antibiotic (18) . Furthermore, it has anti-microbial, anti-inflammatory, anti-thrombosis and anti-cancer activities (14) . Additionally, it protects against coronary disease, lowers cholesterol in serum and liver and increases sperm viability (19) . P-CA has chemoprotectant and anti-oxidant effects (20) , and it is believed to reduce the risk of stomach cancer by reducing the formation of carcinogenic nitrosamines (21, 22) . Kaemperol and quercetin are flavonoids that have many biological activities, including anti-cancer, antiinflammatory and reverse tumor cells an multiple drug resistance effects (23) . Collectively, this indicates that p-CA, FA, kaemperol, quercetin and OA may be the five primary bioactive components of Oldenlandia diffusa.
Several methods have been described to determine Oldenlandia diffusa extract. Liang et al. (24) used highperformance liquid chromatography (HPLC) to analyze ursolic acid, oleanolic acid, asperuloside, E-6-O-p-coumaroyl scandoside methyl ester and E-6-O-p-coumaroyl scandoside methyl ester-10-O-methyl ether in Oldenlandia diffusa. Razborsek et al. (25) used gas chromatography-mass spectrometry (GC-MS) after derivatization to determine OA in Lamiaceae. Song et al. (26) and Ji et al. (27) developed a sensitive LC-MS method to determine the plasma concentration of OA in human and rodents, respectively. However, there is no method established for the simultaneous measurement of these five constituents in Oldenlandia diffusa; therefore, simultaneous determination of these five bioactive components in biological fluids for pharmacokinetic investigations is required. In this article, a simple, rapid and sensitive method for the simultaneous determination of OA, p-CA, FA, kaemperol and quercetin in rat plasma and its application to a pharmacokinetic study of Oldenlandia diffusa extract in rats are described.
Materials and Methods

Herbal materials and chemicals
Oldenlandia diffusa was purchased from a pharmacy called Xing Yuan Chun in Guangzhou, and authenticated by Prof. Rong Zhang. The Oldenlandia diffusa extract was prepared by refluxing with 75% ethanol and the powder was obtained by rotary evaporation under vacuum at 558C, and the extraction ratio was approximately 10%. The contents of all five components in the Oldenlandia diffusa extract are 0.175% for OA, 0.837% for p-CA, 0.021% for FA, 0.024% for kaemperol and 0.171% for quercetin, respectively. OA, p-CA, FA, kaemperol, quercetin and glycyrrhetinic acid (GA, internal standard) ( Figure 1 ) were all obtained from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). HPLC-grade methanol, formic acid and acetonitrile were products of Merck (Darmstadt, Germany). HPLC-grade ethyl acetate was obtained from Fisher. Deionized water was purified using an ultrapure water purification system (Research/Unique-R20). The other reagents were of the highest quality available.
Preparation of calibration standards and quality control samples Primary stock solutions of OA, p-CA, FA, kaemperol and quercetin were prepared in methanol. Working standard solutions of OA, p-CA, FA, kaemperol and quercetin were prepared by combining aliquots of each primary stock solution and diluting with methanol. The working solution for GA (5 mg/mL) was prepared by diluting an aliquot of stock solution with methanol.
Rat plasma calibration standards of OA (1.0, 2.5, 5.0, 10.0, 25.0, 50 and 100 ng/mL), FA, kaemperol, quercetin (0.5, 1.0, 2.5, 5.0, 12.5, 25.0 and 50.0 ng/mL) and p-CA (50, 100, 250, 500, 1,000, 2,500 and 5,000 ng/mL) were prepared by spiking the working standard solutions into a pool of drug-free rat plasma. Quality control (QC) samples of OA (1.5, 10.0 and 100 ng/mL), FA, kaemperol, quercetin (1.5, 5.0 and 50.0 ng/mL) and p-CA (50, 500, 5,000 ng/mL) was prepared in bulk by adding 10 mL of the appropriate working standard solutions to drug-free rat plasma. All standard solution was stored at 48C when not in use.
Sample preparation
Plasma samples (100 mL) spiked with 10 mL of internal standard working solution and 10 mL of 0.1M hydrochloric acid were extracted with 1 mL of ethyl acetate in 1.5-mL polypropylene tubes by vortex mixing for 15 min and centrifuging at 8,000 Â g for 10 min at 48C. The upper organic phase (900 mL) was transferred and evaporated to dryness in a water bath at 408C under a nitrogen stream. The residues were reconstituted in 100-mL aliquots of methanol and centrifuged at 12,000 Â g for 10 min at 48C, and 5 mL of supernatants were injected into LC-MS-MS for analysis.
Chromatographic and mass spectrometric conditions Analyses were performed on an Agilent Series 1200 series liquid chromatography system consisting of a G1311A Quart pumps, a G1322A degasser, a G1313A ALS and a G1316A TCC (Agilent Technologies; Santa Clara, CA) interfaced to an API4000 triple quadrupole mass spectrometer (Applied Biosystem/MDS-SCIEX; Foster City, CA) with an electrospray Turbo Ion source (ESI) in negative mode. The operation conditions were optimized by infusing diluted stock solutions of each analyte as follows: nebulizer gas (gas 1), nitrogen, 30 psi; turbo gas (gas 2), nitrogen, 20 psi; curtain gas, nitrogen, 15 psi; collision gas, nitrogen, 6; ion spray voltage, -4,500 V; source temperature, 3508C with multiple reaction monitoring (MRM). The separation was performed on a Gemini C18 110A column (5 mm, 2.0 mm i.d. Â 50 mm, Phenomenex), and the column temperature was kept at 408C. The mobile phase consisted of 0.01% formic acid in water (solvent A), methanol (solvent B) and acetonitrile (solvent C) was used with a flow rate of 0. tandem mass spectra of the deprotonated molecules of OA, p-CA, FA, kaemperol and quercetin are shown in Figure 2 . The specific parameters for each analyte are shown in Table I .
Method Validation
Selectivity and sensitivity Selectivity is the ability of the analytical method to differentiate and quantify the analyte in the presence of other components in the sample. For selectivity, analyses of blank plasma samples should be obtained from at least six rats. Each blank sample should be tested for interference.
The lower limit of quantification (LLOQ) was defined as the lowest concentration of an analyte in a sample that can be quantitatively determined with acceptable precision and accuracy [% bias and coefficient of variation (CV) less than or equal to 20%]. The limit of detection (LOD) was defined as the lowest concentration of an analyte that the bioanalytical procedure could reliably differentiate from background noise with a signal-to-noise ratio of three.
Calibration curve
The linearity for OA, p-CA, FA, kaemperol and quercetin was evaluated over the range of 1-100, 50-5,000, 0.5-50, 0.5-50 and 0.5-50 ng/mL. Calibration curves of OA, p-CA, FA, kaemperol and quercetin with seven levels were prepared by adding serial diluted working standards to pooled blank plasma. A linear regression model has constructed based on the peak area ratio (y) of the analyte to internal standard versus nominal concentration (x).
Matrix effect and recovery
Matrix effect was examined to ensure that there was no substantial endogenous interference from blank plasma that affected the measurements of OA, p-CA, FA, kaemperol and quercetin in the rat plasma. Matrix effects caused by ionization competition among OA, p-CA, FA, kaemperol and quercetin and endogenous co-eluting components were assessed at three concentrations by comparing the peak areas of the OA, p-CA, FA, kaemperol and quercetin from blank plasma (A1) and the neat QC standards (A2). The absolute recoveries of OA, p-CA, FA, kaemperol, and quercetin from plasma were calculated by comparing the peak areas from the standards spiked before and after extraction in plasma at three concentration levels. The accuracy of the assay was expressed by (mean observed concentration -spiked concentration) / (spiked concentration) Â 100%.
Precision and accuracy
Stability
The stock solutions of OA, p-CA, FA, kaemperol and quercetin were tested at 48C for 30 days. The freeze-thaw stability was evaluated by analyzing the QC plasma samples at three concentration levels after three cycles from 2708C to room temperature. The autosampler stability was assessed by keeping the processed QC plasma samples at room temperature for 24 h. Long-term storage stability was evaluated by freezing the QC plasma samples at -708C for seven or 14 days, and then comparing the concentrations with those of QC plasma samples before the storage period. Figure 3 . Representative MRM chromatograms for blank plasma (A); blank plasma spiked with 0.5 ng/mL OA, 0.1 ng/mL p-CA, 0.5 ng/mL FA, 0.5 ng/mL kaemperol, 0.5 ng/ mL quercetin and 0.5 ng/mL GA (IS) (B); blank plasma spiked with 50 ng/mL OA, 500 ng/mL p-CA, 50 ng/mL FA, 10 ng/mL kaemperol and 2.5 ng/mL quercetin with 500 ng/mL GA (IS) (C); plasma samples of 45 min after oral administration of Oldenlandia diffusa extract with 500 ng/mL GA (D).
Application of the method and pharmacokinetic study
The application of the developed assay was demonstrated in a pharmacokinetic study of Oldenlandia diffusa extract after oral administration to rats. The Experimental Animal Center of Guangdong province (Guangzhou, China) supplied six male Sprague-Dawley rats, weighing 300 + 20 g. The Animal Ethics Committee of Guangzhou University of Chinese Medicine approved the study. Rats were fasted for 12 h before dosing, with free access to water. The rats were weighed and administered a 10 g/kg dose of Oldenlandia diffusa extract (equivalent to 17.5 mg/kg for OA, 83.7 mg/kg for p-CA, 2.1 mg/kg for FA, 2.4 mg/kg for kaemperol and 17.1 mg/kg for quercetin, respectively). Oldenlandia diffusa extract dissolved in 0.5% CMC-Na. Serial blood samples ( 0.25 mL each at 0, 10, 20, 30, 45, 60, 120, 180, 240, 360, 480 and 600 min after administration) were collected in heparinzed tubes by puncture of the orbital sinus of the rats. Plasma was obtained by centrifugation at 1,500 Â g for 10 min at 48C and stored in polypropylene tubes at -708C until assay.
Data analysis
Data are expressed as mean + standard deviation (SD). The pharmacokinetic parameters were estimated by a noncompartmental analysis. The maximum plasma concentrations (C max ) and the time to reach maximum plasma concentrations (T max ) were determined by visually inspecting the experimental data. Elimination rate constant (K el ) and absorption rate constant (K a ) were calculated from slopes by regression analysis. Moreover, the half-life (t 1/2 ) was calculated based on the following equation: t 1/2b ¼ 0.693/K el , t 1/2a ¼ 0.693/K a . The area under the plasma concentration-time curve from time zero to the last measurable concentration (AUC 0!t ) was calculated using the linear trapezoidal rule and was extrapolated to infinity (AUC 0!1 ) according to the relationship AUC0 !1 ¼ AUC 0!t þ C t /k el , where C t is the last concentration evaluated in plasma.
Results and Discussion
Selectivity
No endogenous interfering substances were observed at the retention times of OA, p-CA, FA, kaemperol, quercetin or GA in chromatograms obtained from control blank plasma samples from six rats. Therefore, it was expected that a high and acceptable selectivity could be obtained by this method. Representative chromatograms are shown in Figure 3 .
Sensitivity
The LOD was defined as the amount that could be detected with a signal-to-noise ratio of three. The LODs for OA, p-CA, FA, kaemperol and quercetin were 0.2, 0.05, 0.1, 0.1 and 0.1 ng/mL, respectively. The LLOQs were 0.5, 0.1, 0.5, 0.5 and 0.5 ng/mL for OA, p-CA, FA, kaemperol and quercetin.
Linearity of calibration
All linear regressions of OA, p-CA, FA, kaemperol and quercetin in rat plasma displayed good linear relationships over the ranges of 1 -100, 50 -5,000, 0.5 -50, 0.5 -50 and 0.5 -50 ng/mL, respectively. The mean values of regression equations of the analytes in rat plasma were:
Recovery
Results from the determination of the absolute recovery of OA, p-CA, FA, kaemperol and quercetin from rat plasma are shown in Table II (n ¼ 5 for each concentration). The mean recoveries for OA (1.5, 10 and 100 ng/mL) were 64.43, 62.88 and 61.36%; for p-CA (50, 500 and 5,000 ng/mL) were 77.63, 70.11 and 77.70%, respectively; for FA (1.5, 5 and 50 ng/mL) were 73.06, 74.58 and 72.88%, respectively; for kaemperol (1.5, 5 and 50 ng/mL) were 66.17, 61.83 and 72.69%, respectively; for quercetin (1.5, 5 and 50 ng/mL) were 61.33, 69.95 and 63.54%, respectively.
Matrix effect
Matrix effect caused by ionization competition among OA, p-CA, FA, kaemperol and quercetin or endogenous co-eluting components were evaluated at three concentrations (n ¼ 5).
The results are shown in Table III .
Precision and accuracy
The precision and accuracy of the method were assessed in plasma by performing replicated analyses of spiked samples against calibration standards. The intra-day and inter-day precision and accuracy of the method are shown in Table IV .
Stability
Stability data is summarized in Table V , which indicates that the five analytes are stable in plasma for at least three freeze-thaw cycles. Moreover, the results of the stability showed that all Table VI . The information described herein might be helpful for further studies on the pharmacokinetics of Oldenlandia diffusa.
Conclusion
This paper described a simple, rapid, sensitive and validated LC-MS-MS bioanalytical method for simultaneous determination of OA, p-CA, FA, kaemperol and quercetin in rat plasma after oral administration of Oldenlandia diffusa extract, as well as an investigation of their pharmacokinetic studies. The assay provided adequate recovery with good precision and accuracy. The pharmacokinetic results contribute to a better understanding of the pharmacological action mechanism, and provide a firm basis for evaluating the clinical efficacy of Oldenlandia diffusa. 
